Henry F Blissenbach - Net Worth and Insider Trading
Henry F Blissenbach Net Worth
The estimated net worth of Henry F Blissenbach is at least $551,749 dollars as of 2024-11-13. Henry F Blissenbach is the President and CEO of Option Care Health Inc and owns about 24,136 shares of Option Care Health Inc (OPCH) stock worth over $551,749. Details can be seen in Henry F Blissenbach's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Henry F Blissenbach has not made any transactions after 2005-03-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Henry F Blissenbach
Henry F Blissenbach Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Henry F Blissenbach owns 2 companies in total, including Ligand Pharmaceuticals Inc (LGND) , and Option Care Health Inc (OPCH) .
Click here to see the complete history of Henry F Blissenbach’s form 4 insider trades.
Insider Ownership Summary of Henry F Blissenbach
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2006-07-27 | director |
| OPCH | Option Care Health Inc | 2005-03-12 | director & President and CEO |
Henry F Blissenbach Latest Holdings Summary
Henry F Blissenbach currently owns a total of 1 stock. Henry F Blissenbach owns 24,136 shares of Option Care Health Inc (OPCH) as of March 12, 2005, with a value of $551,749.
Latest Holdings of Henry F Blissenbach
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OPCH | Option Care Health Inc | 2005-03-12 | 24,136 | 22.86 | 551,749 |
Holding Weightings of Henry F Blissenbach
Henry F Blissenbach Form 4 Trading Tracker
According to the SEC Form 4 filings, Henry F Blissenbach has made a total of 0 transactions in Option Care Health Inc (OPCH) over the past 5 years. The most-recent trade in Option Care Health Inc is the sale of 0 shares on March 12, 2005, which brought Henry F Blissenbach around $0.
Insider Trading History of Henry F Blissenbach
- 1
Henry F Blissenbach Trading Performance
Henry F Blissenbach Ownership Network
Ownership Network List of Henry F Blissenbach
Ownership Network Relation of Henry F Blissenbach
Henry F Blissenbach Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Henry F Blissenbach is the director of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include CHIEF LEGAL OFFICER & Andrew Reardon , VP & Finance and CFO Matthew E Korenberg , and Chief Financial Officer Octavio Espinoza .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Henry F Blissenbach made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 70,748 shares made by Matthew E Korenberg , a net sale of 14,708 shares made by Octavio Espinoza , and a net sale of 13,500 shares made by Andrew Reardon .
In summary, during the past 3 months, insiders sold 39,680 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 39,680 shares. During the past 18 months, 106,227 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 99,727 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Henry F Blissenbach Mailing Address
Above is the net worth, insider trading, and ownership report for Henry F Blissenbach. You might contact Henry F Blissenbach via mailing address: 607 Pond View Dr, Mendota Heights Mn 55120.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
